Sebia, the global leader in clinical electrophoresis equipment and reagents, offers both capillary separation and agarose gel technologies. Sebia continues to innovate with our latest generation of instruments, the CAPILLARYS 3 TERA family including OCTA.
Sebia’s automated portfolio, the CAPILLARYS 3 TERA family, CAPILLARYS 2 Flex Piercing, and MINICAP Flex Piercing systems, provide full walkaway capability and workload flexibility on our multi-assay instruments. Menu includes serum & urine protein and Immunotyping (automated IFE), hemoglobinopathy, CDT, and HbA1c for diagnosis and monitoring. The ability to add a tube loader with the CAPILLARYS 3 TERA allows for custom configuration of our MC family for added capacity and work cell productivity.
Sebia’s automated agarose gel electrophoresis system, HYDRASYS 2 SCAN with ASSIST, has the only assay (HYDRASHIFT) available to remove interference from daratumumab therapy; along with our full menu for routine and esoteric testing.